Suppr超能文献

基于奈福泮的患者自控镇痛联合或不联合芬太尼对腹腔镜胆囊切除术后患者疼痛强度的影响:一项前瞻性、随机、对照、双盲非劣效性试验

Effect of Nefopam-Based Patient-Controlled Analgesia with and without Fentanyl on Postoperative Pain Intensity in Patients Following Laparoscopic Cholecystectomy: A Prospective, Randomized, Controlled, Double-Blind Non-Inferiority Trial.

作者信息

Jung Ki Tae, So Keum Young, Kim Seung Chul, Kim Sang Hun

机构信息

Department of Anesthesiology and Pain Medicine, School of Medicine, Chosun University, 309 Pilmun-Daero, Dong-Gu, Gwangju 61452, Korea.

Department of Anesthesiology and Pain Medicine, Chosun University Hospital, 365 Pilmun-Daero, Dong-Gu, Gwangju 61453, Korea.

出版信息

Medicina (Kaunas). 2021 Mar 27;57(4):316. doi: 10.3390/medicina57040316.

Abstract

: We investigated the non-inferiority of patient-controlled analgesia (PCA), using either nefopam alone or combined nefopam-fentanyl for postoperative analgesia in patients undergoing laparoscopic cholecystectomy. : In this prospective, randomized, controlled study, 78 patients were allocated to receive nefopam 240 mg (Group N240) or nefopam 120 mg with fentanyl 600 μg (Group NF), equivalent to fentanyl 1200 μg, with a total PCA volume of 120 mL. Patients were given a loading dose (0.1 mL/kg) from the PCA device along with ramosetron (0.3 mg) and connected to a PCA device with a background infusion rate of 2 mL/h, bolus dose amount set at 2 mL, and lockout interval set at 15 min. Pain scores were obtained using the numeric rating scale (NRS) at 30 min after recovery room (RR) admission, as well as 8 and 24 h postoperatively. The primary outcome was analgesic efficacy evaluated using NRS-rated 8 h postoperatively. Other evaluated outcomes included the incidence rate of bolus demand, rescue analgesic and antiemetic requirements, and postoperative adverse effects. : NRS scores were not significantly different between the groups throughout the postoperative period ( = 0.539). NRS scores of group N240 were not inferior to those of group NF at 30 min after RR admission, or at 8 and 24 h postoperatively (mean difference [95% CI], -0.05 [-0.73 to 0.63], 0.10 [-0.29 to 0.50], and 0.28 [-0.06 to 0.62], respectively). Postoperative adverse effects were not significantly different between the two groups ( = 1.000) and other outcomes were also not significantly different between the two groups ( ≥ 0.225). : PCA using nefopam alone has a non-inferior and effective analgesic efficacy and produces a lower incidence of postoperative adverse effects compared to a combination of fentanyl and nefopam after laparoscopic cholecystectomy.

摘要

我们研究了在接受腹腔镜胆囊切除术的患者中,单独使用奈福泮或联合使用奈福泮 - 芬太尼进行患者自控镇痛(PCA)的非劣效性。

在这项前瞻性、随机、对照研究中,78例患者被分配接受240mg奈福泮(N240组)或120mg奈福泮与600μg芬太尼(NF组,相当于1200μg芬太尼),PCA总量为120mL。患者从PCA装置接受负荷剂量(0.1mL/kg)以及雷莫司琼(0.3mg),并连接至PCA装置且背景输注速率设定为2mL/h,推注剂量设定为2mL,锁定时间设定为15分钟。在恢复室(RR)入院后30分钟以及术后8小时和24小时使用数字评分量表(NRS)获得疼痛评分。主要结局是使用术后8小时NRS评分评估的镇痛效果。其他评估结局包括推注需求发生率、补救性镇痛和止吐需求以及术后不良反应。

在整个术后期间,两组之间的NRS评分无显著差异(P = 0.539)。N240组的NRS评分在RR入院后30分钟、术后8小时和24小时均不劣于NF组(平均差异[95%CI]分别为 -0.05[-0.73至0.63]、0.10[-0.29至0.50]和0.28[-0.06至0.62])。两组之间的术后不良反应无显著差异(P = 1.000),并且两组之间的其他结局也无显著差异(P≥0.225)。

与腹腔镜胆囊切除术后芬太尼和奈福泮联合使用相比,单独使用奈福泮进行PCA具有非劣效且有效的镇痛效果,并且术后不良反应发生率更低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2360/8067158/a48ef3b2f474/medicina-57-00316-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验